Orbimed Advisors LLC Repare Therapeutics Inc. Call Options Transaction History
Orbimed Advisors LLC
- $2.8 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RPTX
# of Institutions
56Shares Held
30.8MCall Options Held
163KPut Options Held
0-
Bvf Inc San Francisco, CA10.3MShares$18.6 Million0.56% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.44MShares$6.2 Million2.59% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$5.34 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$4.76 Million6.53% of portfolio
-
Redmile Group, LLC San Francisco, CA1.59MShares$2.86 Million0.27% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $75.5M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...